<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Shahbazi Ss</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=practice+P92639">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where Shahbazi Ss is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1310020E0&amp;denomIds=13.10.2&amp;selectedTab=summary">Bifonazole</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Antifungal preparations</td>
      <td>16</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>53.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1310020E0AAAAAA&amp;denomIds=13.10.2&amp;selectedTab=summary" target="_blank">Bifonazole 1% cream : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1306010N0&amp;denomIds=13.6.1&amp;selectedTab=summary">Nicotinamide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Topical preparations for acne</td>
      <td>30</td>
      <td>0.17</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>22.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1306010N0AAAAAA&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Nicotinamide 4% gel : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1104020N0&amp;denomIds=11.4.2&amp;selectedTab=summary">Nedocromil sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Other anti-inflammatory preparations</td>
      <td>48</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>13.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1104020N0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Nedocromil 2% eye drops : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0504010U0&amp;denomIds=5.4.1&amp;selectedTab=summary">Proguanil hydrochloride with atovaquone</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Antimalarials</td>
      <td>44</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>13.09</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0504010U0BBAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Malarone 250mg/100mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0408020Q0&amp;denomIds=4.8.2&amp;selectedTab=summary">Paraldehyde</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Drugs used in status epilepticus</td>
      <td>8</td>
      <td>0.75</td>
      <td>0.01</td>
      <td>0.08</td>
      <td>9.43</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0408020Q0AAAJAJ&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Paraldehyde 50% in Olive oil rectal solution : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Shahbazi Ss is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>15</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>25</td>
      <td>0.60</td>
      <td>0.95</td>
      <td>0.07</td>
      <td>-5.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0902021X0&amp;denomIds=9.2.2&amp;selectedTab=summary">Water for injection</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Electrolytes and water</td>
      <td>13</td>
      <td>0.00</td>
      <td>0.82</td>
      <td>0.26</td>
      <td>-3.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0&amp;denomIds=5.1.1&amp;selectedTab=summary">Amoxicillin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>41</td>
      <td>Broad-spectrum penicillins</td>
      <td>68</td>
      <td>0.60</td>
      <td>0.81</td>
      <td>0.09</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0AAASAS&amp;denomIds=5.1.1&amp;selectedTab=summary" target="_blank">Amoxicillin 125mg/5ml oral suspension sugar free : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0AAAKAK&amp;denomIds=5.1.1&amp;selectedTab=summary" target="_blank">Amoxicillin 250mg/5ml oral suspension : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0AAATAT&amp;denomIds=5.1.1&amp;selectedTab=summary" target="_blank">Amoxicillin 250mg/5ml oral suspension sugar free : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0AAABAB&amp;denomIds=5.1.1&amp;selectedTab=summary" target="_blank">Amoxicillin 500mg capsules : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0501013B0AAAJAJ&amp;denomIds=5.1.1&amp;selectedTab=summary" target="_blank">Amoxicillin 125mg/5ml oral suspension : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0407042Q0&amp;denomIds=4.7.4&amp;selectedTab=summary">Pizotifen malate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Prophylaxis of migraine</td>
      <td>15</td>
      <td>0.07</td>
      <td>0.65</td>
      <td>0.26</td>
      <td>-2.24</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHzUlEQVR4nO3dbYwdVR3H8e8sVR7Lg4AFbWXaxj5IWSnQQoWlNaggUwjCi4IxIVpDfKWJbxgN8RUxQ0iM0TeIIqIJsS9AVAZiImELxba2WyDQlEILI6DW1oAVqqVgjy/+53q3l127d++9c+7c+X2Sk22b7r3/vdnfnDNn5pyJnHOISD0MhS5ARMqjwIvUiAIvUiMKvEiNKPAiNaLAi9SIAi9SIwq8SI0o8CI1osCL1Ei4wEeR7ukVKdmM0AVIvcVpfgwwB5gHzPVtDjATOAk40X91wIFx7S3gdeBV314DdhdZ8q+Sf4RKiYItnokih3NRmDeXEHy4lwAXAhf4Nhf4E/DKuPYq8E/gbd8OABEW/kY7Bfgo8LFxbT5wGNgBbPdtDHihyJL/lPEz9jsFXnomTvMZwPnASmAVFvQXgC3ANiyMLxdZcriL7zkTWAycC5yHHVQWArv8+2317cVuvm9VKPDSNT7gS7Fwr8TC9jywHhgFthRZcihAXUPAAuAi3y7ERgNPA0/6trXIknfKrq1sCrxMW5zmH8BCvQoL+PnAc1i412MhKj3gUxGn+Qex4I/41jg4PQI8CrxUZEnQieU4zU/HRiuHge1Fluzv9DUVeJkyH/CLaA7Rh4FnaQZ8rMiSd0PV1wk/v7AM+Lxvp2LhXwdsKiv8cZqfA3wZ+BJwCDsFGgI+gc1l3FZkST7d11fgZVK+F1xGM+BLsGFwY4i+rciS90LV10txmn8YuAZYgw3/H8TCP9aL8MdpPg/4DnAp8BPgviJL9rT8nwuAO4ssuWK676PAy//4c92lwJXAp7GJrzGaAX9mUAP+//jw3wDcCJwF/BK4v8iSnV147dnAbcBngAwL+qSjpDjNo04OOAp8zcVp/iEgAa4CLgdeBH4HPIYFXJezxonTfA7W638RuzfgfmBdkSWvt/k6C4FvYJ/794AflzFpqMDXUJzmZwLXYb3WIiDHJqpGiyx5O2RtVRKn+SLgJuwAsBc7UD4OPFtkyYGW/xsBs7GD6xf8n38A/KLMm4UU+JrwE27XALdgl6geAh4ANtbxenQ3+TAPA1dgp0JLsBuF9gHvAscDZwN7sIPCbwj0uSvwAy5O8xj4KjbruxG4G1ivkPdWnOYnAKdjt68fAv7aD5+5Aj+AfG++GuvN59Kc9d0XtDAJToEfIP4abqM33wz8CDsv18pEAbRarvL87ayN3nwecA9wcZEle4MWJn1JPXxFxWk+l+YdWX/Ezs1H++E8UfqXevgK8RNB1wNfwW4AuRe4RL25TJV6+D7nL/lcjPXmV2PXy++lxPu7ZXAo8H3K39Sxxre/YSF/oPWGDpF2aEjfJ3xPvhAbsq/BbthYB1xdZEkRsDQZIAp8QP56+Qg2y54A/wB+DdxQZMmukLXJYNKQvkRxmh8PLAcuw4I+jM2w/xbIW5dDinSbAt9DcZqfhq1vHsFCfg62n9uTwAbg6apuGCHVpMB3kV862ei9R4ATgKdo7pu2UzPrEpICP01+km0xzd77Umyv9EbvvaHdNdIivabAT9G4DRsbAV+G7aHeCPgfiix5M1yFIkenwE8iTvOTgEtoDs8XYRs2NobnW4osORiuQpH2KfCe37fsMprn4LOw9eMbsIA/p+2epOo6CrxfjnkydpPIfuDvU551Dhj4OM2PwzZrXI7dtroceI9muDdgT0TRBJsMlE4Dvxl7BtgM7Flfs7BngW2n2Ttum3BzvpIC7y+NnYttOzSMnXufDTyDrRnfjA3Pdf4tA6/rQ3ofsPOAT2HD46XAbuzy1EZsL6993Qy83175I9j+4fOx2fMl2Ob972BPFHkeeyrKVqBQ7y111PNzeB/GxdgBYIX/GhV3rF4Q3/rwt4Gd2NNC/wK8CRwsssT5y17H+nYccCa2JHSW/9p4Wug84DT//S9jB5cdWMB36PHBIk1BJu3iND+juGP1vvjWh7+JLRiZjfXQp2I7fILt+X0I66EPYjuA7hnX/oyFezfwhnpskaPTLL1IjQyFLkBEyqPAi9SIAi9SIx0FPoqiW6b9zQHO3zuqN5Cq1Vy1eqF6NXdSb6c9fKU+KKpXL1Sv5qrVC9WrOVjgRaRCFHiRGuk08Hd3pYryVK1eqF7NVasXqlfztOsNd+ONiJROQ3qRGmlrX/ooii7HFr/sdc79NIqi67EFLLucc7/qRYGdmqDmm7Hlso865x4PW937tdbr/+0u4GfOuU1Bi5vEBJ/xCLZQapNz7omw1b3fBPWuBWYCOOe+H7S4SURRtAr4mnPuRv/3tdhCsvXOuaem+jrt9vArnHMZtnIN4OPOuTuBBW2+TpmOqNk5dx9wF7bKrh8dUa8/qI4GrejoWn8vrgX+DfTrk2xb6z0GC0/fPpTTOTeK7eHQcIZz7rvYEvQpazfwrSf8VZgAOKLGKIpOBNYCPw9TzlG1fqbDNHfF7VetNZ/snPsh8LkQxUxBa71DzrlvYaPVqphW9tqatPNDoRXAG8A27MEK84GXnHMPTaeAXpug5q8Du4DfO+c2hqxtIq31OufG/HDuYJ8P6Vt/L2Jgv3PunoClTWiCelcCEfCWc64vZ+yjKPokcDuwCeusPouNSp5oZ0ivWXqRGtEsvUiNKPAiNaLAi9SIAi9SIwq8SI0o8CI1osCL1IgCL1IjCrxIjSjwIjWiwIvUyH8BDi0aZ6jrPuoAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=0407042Q0AAABAB&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Pizotifen 500microgram tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P92639&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Preparations for warts and calluses</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.69</td>
      <td>0.31</td>
      <td>-2.20</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>